Related Experiment Video
Updated: Apr 23, 2026
07:48
Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
13.9K
Human endotoxin administration as an experimental model in drug development
1Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Clinical Pharmacology and Therapeutics
|September 20, 2014
Summary
Bacterial endotoxin challenges in humans reveal key inflammatory mechanisms and test new treatments. This research links in vitro findings to human physiology for better understanding of innate immunity in health and disease.
Area of Science:
- Immunology
- Human Physiology
- Inflammation Research
Background:
- Innate immunity is central to inflammatory responses in health and disease.
- Bacterial endotoxin is a primary trigger of innate immune responses.
- Understanding in vivo human inflammatory mechanisms is crucial.
Purpose of the Study:
- To demonstrate key inflammatory mechanisms in humans using endotoxin.
- To evaluate novel inflammation-modifying agents in human subjects.
- To bridge findings from in vitro/animal models to human physiology.
Main Methods:
- Administration of bacterial endotoxin to human participants.
- Observation and measurement of resulting inflammatory responses in vivo.
- Testing of therapeutic agents targeting inflammation.
Main Results:
- Endotoxin challenges successfully demonstrated specific inflammatory pathways in humans.
- The in vivo relevance of in vitro and animal model findings was assessed.
- Novel agents were evaluated for their capacity to modify endotoxin-induced inflammation.
Conclusions:
- Human endotoxin challenges are vital for validating inflammatory mechanisms.
- This approach facilitates the translation of basic research to clinical applications.
- Endotoxin models provide a platform for developing new anti-inflammatory therapies.
